Difference between revisions of "Breast cancer BRCA1 & BRCA2 genetic testing"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "font-size:200%"> Hello!<br>  We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br>  Please help us by filling it out!<br>" to "font-size:300%"> Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>")
m (Text replacement - "Just 10 days left" to "Just 9 days left")
Line 1: Line 1:
 
{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center"  
 
{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center"  
 
|
 
|
<span style="font-family:Arial; font-size:300%">&nbsp;Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>
+
<span style="font-family:Arial; font-size:300%">&nbsp;Just 9 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>
 
&nbsp;'''Link:''' http://j.mp/2BlBaoQ
 
&nbsp;'''Link:''' http://j.mp/2BlBaoQ
 
</span>
 
</span>

Revision as of 13:53, 23 January 2018

 Just 9 days left to fill out a survey on how we can make HemOnc.org better and more useful.
 Link: http://j.mp/2BlBaoQ


Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.

Criteria for BRCA1/BRCA2 genetic testing

This is from a clinical trial protocol and is similar to, but not identical to, the NCCN breast cancer familiar risk assessment guidelines.[1] Additional resources can be found at the links below.[2][3]

  • Breast cancer diagnosed ≤45 years old
  • Diagnosed at age ≤50 years old with:
    • first, second, or third-degree blood relative with breast cancer diagnosis ≤50 years old
    • and/or epithelial ovarian or fallopian peritoneal cancer at any age
  • Diagnosed at age <60 years old with a triple negative breast cancer
  • Two breast primaries--that is, bilateral disease or two or more clearly separate ipsilateral primary tumors--when first breast cancer diagnosis occurred prior to age 50
  • Personal history of epithelial ovarian, fallopian tube, or primary peritoneal cancer
  • Diagnosed at any age with ≥2 first, second, or third-degree relatives with breast and/or epithelial ovarian, fallopian tube, or primary peritoneal cancer at any age
  • First or second-degree relative of anybody known to carry a harmful BRCA1 or BRCA2 mutation
  • Ashkenazi Jewish descent
  • Male breast cancer
  • First, second, or third-degree male relative with breast cancer

References